The inhibition of CYBB in zebrafish embryos leads to lipid metabolism disorders and excessive activation of the TLR4/NF-κB pathway, triggering liver injury and immune-inflammatory responses (62). This evidence concerns the gene NFKB1 and Disorder of lipid metabolism.